UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in ANIP — Ani Pharmaceuticals Inc
CIK 861177
NEW YORK, NY
Position in ANIP
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,499,853
+$978,919 QoQ
Shares Held
42,279
+29.0% QoQ
Ownership
0.184%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 305 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 35%
Shared 0%
None 65%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $852,377,607 across 33 Drug Manufacturers - Specialty & Generic names. ANIP ranks #16 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,924,988 | $282,049,632 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,832,465 | $129,843,910 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
218,164 | $118,207,795 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
504,233 | $84,983,427 | |
| 5 | VTRS |
Viatris Inc
|
4,293,757 | $68,184,856 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
482,743 | $53,555,505 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
1,510,327 | $37,169,144 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
425,977 | $14,768,619 |
All Filings in ANIP
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,499,853 | 42,279 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,520,934 | 32,782 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,436,638 | 30,867 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,717,404 | 29,666 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,629,466 | 55,624 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,235,157 | 48,322 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $2,647,856 | 47,899 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,025,516 | 33,951 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,736,389 | 42,971 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,074,001 | 15,536 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $856,654 | 15,536 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $902,018 | 15,536 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $546,533 | 10,153 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $403,274 | 10,153 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $204,849 | 5,092 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $208,427 | 6,485 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $241,008 | 8,123 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $213,888 | 7,609 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $350,621 | 7,609 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $249,726 | 7,609 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $266,694 | 7,609 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $245,101 | 6,782 | Shares | Defined | 2021-05-14 | |
| 2020-03-31 | $234,091 | 5,746 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||